My watch list  

10 Current news from israel

matching the following criteria

Evogene reports first quarter 2013 financial results


Evogene Ltd. (EVGN) announced its financial results for the first quarter ended March 31, 2013. Revenues for the first quarter of 2013 grew to $4.6 million, compared to $4.2 million for the same period in 2012. Evogene’s current revenues consist primarily of research and licensing revenues ...


WITec appoints new distributor in Israel

Advanced Technological Solutions Ltd. selected as exclusive representative


WITec, worldwide leader in nano-analytical microscopy systems, has appointed Advanced Technological Solutions Ltd. (ATSL) as its exclusive distributor in Israel. From now on ATSL will support WITec’s market entry and promote the full product line of high-resolution SNOM, AFM and Raman Imaging ...


Distribution agreement across Asia between DKSH and Tagra


KSH Business Unit Performance Materials was appointed as distributor for Tagra’s range of encapsulated actives, oils and pigments. The products are developed and produced by applying Tagra’s manufacturing technology, RND™ (Release On Demand), which seals each micro-capped ingredient from chemical ...


Evogene Expands Research and Development Facilities by Over 50%


Evogene Ltd. announced completion of an expansion program of its R&D facilities, resulting in a greater than 50% increase in the company's gene validation & plant growth capacity. The expansion was conducted in two stages: the first stage included reconstruction of new molecular and tissue ...


Evogene to Establish Evofuel Ltd. for Developing Advanced Feedstock for Biofuel

Wholly owned Subsidiary Expanding Castor Bean Activity in Brazil


Evogene Ltd. announced that it is establishing Evofuel, a wholly owned subsidiary, to focus on developing seed for advanced second-generation feedstock for biofuel. Included in the activities that are being transferred from the parent company to Evofuel is the development and commercialization ...


Epigenomics Signs Distribution Deal with Pronto Diagnostics for Epi proColon in Israel

Epigenomics expands commercial reach for CE-marked product beyond home market


Epigenomics AG and Pronto Diagnostics Ltd. announced that they have signed an exclusive distributor agreement for the commercialization of Epigenomics’ Epi proColon test in Israel. Epi proColon is the world’s first CE-marked molecular diagnostic test for the early detection of colorectal cancer ...


Teva Receives European Commission Approval for ratiopharm Acquisition


Teva Pharmaceutical Industries Ltd. announced that the Company received approval from the European Commission to proceed with its acquisition of ratiopharm. In connection with this approval and following the Commission's review of this transaction, Teva made certain limited commitments, which are ...


NasVax: Closing Share Purchase Agreement of Protea Vaccine Technologies

Protea has become a fully owned subsidiary of NasVax


NasVax Ltd. announced that it has closed the purchase of 100% of the shares of Protea Vaccine Technologies of Kiryat Shmona Israel. As a result, Protea has become a fully owned subsidiary of NasVax. In June 2009, Protea announced that it signed a Research and License Option Agreement with ...


Sun Pharmaceutical Extends Tender Offer for Taro


Sun Pharmaceutical Industries Ltd. announced its subsidiary, Alkaloida Chemical Company Exclusive Group Ltd. (Alkaloida), has extended the Expiration Date of the Tender Offer for the purchase of all outstanding Ordinary Shares of Taro Pharmaceutical Industries Ltd. The Offer will now expire at ...


NasVax Finalizes Share Purchase Agreement with Protea Vaccine Technologies


NasVax Ltd. announced that it has signed an agreement with Protea Vaccine Technologies Ltd (Protea) to purchase all of the company's shares. Protea is developing an innovative next-generation vaccine against diseases caused by Streptococcus pneumoniae, based on widely conserved pneumococcal ...


Page 1 From 1
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE